Brain Science Foundation Receives $10,000 from Meningioma Mommas
Donation Will Help Advance Research on the Genetic Risk Factors for Meningioma
The Brain Science Foundation has been awarded a gift from online support group, Meningioma Mommas, as part of the Foundation’s newly-
 |
| Meningioma Mommas founder Liz Holzemer (in black) presents $10,000 to BSF founder Steven Haley, from left, Dr. Elizabeth Claus and Dr. Peter M. Black. |
launched
program,
The Meningioma Project. BSF Board Member and Meningioma Mommas founder Liz Holzemer presented the BSF with a $10,000 donation that will serve to offset cuts in NIH funding for the
Meningioma Consortium Project, Dr. Elizabeth Claus’s multi-center, multi-dimensional study of the environmental, genetic, pathologic and clinical variables associated with meningioma risk. As a matter of NIH policy this year, all grant recipients received a 29% funding cut.
Specifically, this latest donation from Meningioma Mommas will help the BSF support the collection of genetic pilot data from Massachusetts study subjects over the next several years. As a result of the pilot data generated with this gift, Dr. Claus hopes to secure NIH support for the analysis of genetic data from all subjects in the nationwide study.
By supporting this critical research initiative, the BSF is helping Dr. Claus and her team set the stage for future federal support of research examining the genetic risk factors for meningioma. Current NIH support for the Meningioma Consortium Project includes only environmental risk factors, outcome and quality of life issues associated with meningioma. For more information on the Meningioma Consortium Project, click here.
To date, Meningioma Mommas has provided $25,000 to the Brain Science Foundation specifically for the epidemiological research that Dr. Elizabeth Claus and her colleagues have conducted. In addition to providing an online support group for all those affected by meningioma brain tumors, Meningioma Mommas has partnered with the Brain Science Foundation and the Brigham and Women's Hospital to help raise awareness of meningiomas and to advocate for an improved quality of life for all meningioma patients and survivors. The organization has committed to raising $1 million to advance meningioma-related research.
